Adelaide University researchers have found a DNA "switch" that helps the body stop the growth of the most common form of breast cancer, providing new insights that could help with future treatments. Up to 80% of breast cancer cases are classified as estrogen receptor-positive (ER+)—meaning their growth is driven by the hormone estrogen.